Monday, September 17, 2012

New Test For Autism in Babies


Interesting read regarding a new test for autism.  From an office that preaches nutrition, especially for pregnant mom's and babies, this is an interesting study that could help with early detection and possibly even prevention.

Washington, September 13 (ANI): Australian researchers have come out with a genetic test that can predict the risk of developing Autism Spectrum Disorder, ASD.
Lead researcher Professor Stan Skafidas, Director of the Centre for Neural Engineering at the University of Melbourne said the test could be used to assess the risk for developing the disorder.

"This test could assist in the early detection of the condition in babies and children and help in the early management of those who become diagnosed," he said.

"It would be particularly relevant for families who have a history of Autism or related conditions such as Asperger's Syndrome," he noted.

Autism affects around one in 150 births and is characterized by abnormal social interaction, impaired communication and repetitive behaviors.

The test correctly predicted ASD with more than 70 per cent accuracy in people of central European descent. Ongoing validation tests are continuing including the development of accurate testing for other ethnic groups.

Clinical neuropsychologist, Dr Renee Testa from the University of Melbourne and Monash University, said the test would allow clinicians to provide early interventions that may reduce behavioural and cognitive difficulties that children and adults with ASD experience.

"Early identification of risk means we can provide interventions to improve overall functioning for those affected, including families," she said.

A genetic cause has been long sought with many genes implicated in the condition, but no single gene has been adequate for determining risk.

Using US data from 3,346 individuals with ASD and 4,165 of their relatives from Autism Genetic Resource Exchange (AGRE) and Simons Foundation Autism Research Initiative (SFARI), the researchers identified 237 genetic markers (SNPs) in 146 genes and related cellular pathways that either contribute to or protect an individual from developing ASD.

Senior author Professor Christos Pantelis of the Melbourne Neuropsychiatry Centre at the University of Melbourne and Melbourne Health said the discovery of the combination of contributing and protective gene markers and their interaction had helped to develop a very promising predictive ASD test.

The test is based on measuring both genetic markers of risk and protection for ASD. The risk markers increase the score on the genetic test, while the protective markers decrease the score. The higher the overall score, the higher the individual risk.

"This has been a multidisciplinary team effort with expertise across fields providing new ways of investigating this complex condition," Professor Pantelis said.

The study was undertaken in collaboration with Professor Ian Everall, Cato Chair in Psychiatry and Dr Gursharan Chana from the University of Melbourne and Melbourne Health, and Dr Daniela Zantomio from Austin Health.

The next step is to further assess the accuracy of the test by monitoring children who are not yet diagnosed over an extended study. (ANI)


Thursday, September 6, 2012

Multiple Factors of Low Back Pain





Interesting read regarding sex, age, race, and multiple factors in lower back pain. Chiropractic is specializes in lower back pain amongst many other health related issues.  Our office see's infants to elderly and everything in between for all muscle, joint, nerve related issues.  

Prognostic Factors for Recovery in Chronic Nonspecific Low Back Pain: A Systematic Review
1.     Karin Verkerk
2.     Pim A.J. Luijsterburg
3.     Harard S. Miedema,
4.     Annelies Pool-Goudzwaard and 
5.     Bart W. Koes
+Author Affiliations
1.     K. Verkerk, PT, MSc, Rotterdam University of Applied Sciences, Rotterdam, the Netherlands; Spine & Joint Centre, Rotterdam, the Netherlands; Department of General Practice, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Mailing address: Museumpark 40, 3015 CX Rotterdam, the Netherlands.
2.     P.A.J. Luijsterburg, PhD, Department of General Practice, Erasmus MC, University Medical Center.
3.     H.S. Miedema, MD, Rotterdam University of Applied Sciences.
4.     A. Pool-Goudzwaard, PhD, Department of Neuroscience, Erasmus MC, University Medical Center, Rotterdam.
5.     B.W. Koes, PhD, Department of General Practice, Erasmus MC, University Medical Center.
1.     Address all correspondence to Ms Verkerk at: k.verkerk@hr.nl.
Abstract
Background Few data are available on predictors for a favorable outcome in patients with chronic nonspecific low back pain (CNLBP).
Purpose The aim of this study was to assess prognostic factors for pain intensity, disability, return to work, quality of life, and global perceived effect in patients with CNLBP at short-term (≤6 months) and long-term (>6 months) follow-up.
Data Sources Relevant studies evaluating the prognosis of CNLBP were searched in PubMed, CINAHL, and EMBASE (through March 2010).
Study Selection Articles with all types of study designs were included. Inclusion criteria were: participants were patients with CNLBP (≥12 weeks' duration), participants were older than 18 years of age, and the study was related to prognostic factors for recovery. Fourteen studies met the inclusion criteria.
Data Extraction Two reviewers extracted the data and details of each study.
Data Synthesis A qualitative analysis using “level of evidence” was performed for all included studies. Data were summarized in tables and critically appraised.
Limitations The results of the studies reviewed were limited by their methodological weaknesses.
Conclusions At short-term follow-up, no association was found for the factors of age and sex with the outcomes of pain intensity and disability. At long-term follow-up, smoking had the same result. At long-term follow-up, pain intensity and fear of movement had no association with disability. At short-term follow-up, conflicting evidence was found for the association between the outcomes pain intensity and disability and the factor of fear of movement. At long-term follow-up, conflicting evidence was found for the factors of age, sex, and physical job demands. At long-term follow-up, conflicting evidence also was found for the association between return to work and age, sex, and activities of daily living. At baseline, there was limited evidence of a positive influence of lower pain intensity and physical job demands on return to work. No high-quality studies were found for the outcomes of quality of life and global perceived effect.